Related references
Note: Only part of the references are listed.Acute hepatotoxicity of 2′ fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins
Wen Shen et al.
NUCLEIC ACIDS RESEARCH (2018)
Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides
Shiyu Wang et al.
NUCLEIC ACIDS RESEARCH (2018)
Loss of Sfpq Causes Long-Gene Transcriptopathy in the Brain
Akihide Takeuchi et al.
CELL REPORTS (2018)
A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides
Andreas Dieckmann et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders
Eliezer Calo et al.
NATURE (2018)
Role of Computationally Evaluated Target Specificity in the Hepatotoxicity of Gapmer Antisense Oligonucleotides
Takeshi Kasuya et al.
NUCLEIC ACID THERAPEUTICS (2018)
RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus
Xue-Hai Liang et al.
MOLECULAR THERAPY (2017)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Cellular uptake and trafficking of antisense oligonucleotides
Stanley T. Crooke et al.
NATURE BIOTECHNOLOGY (2017)
Dynamic nucleoplasmic and nucleolar localization of mammalian RNase H1 in response to RNAP I transcriptional R-loops
Wen Shen et al.
NUCLEIC ACIDS RESEARCH (2017)
Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides
Jeffrey K. Bailey et al.
NUCLEIC ACIDS RESEARCH (2017)
Molecular Mechanisms of Antisense Oligonucleotides
Stanley T. Crooke
NUCLEIC ACID THERAPEUTICS (2017)
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs
Piotr J. Kamola et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Electronic Structures of LNA Phosphorothioate Oligonucleotides
Henrik G. Bohr et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Depletion of NEAT1 lncRNA attenuates nucleolar stress by releasing sequestered P54nrb and PSF to facilitate c-Myc translation
Wen Shen et al.
PLOS ONE (2017)
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts
Sebastien A. Burel et al.
NUCLEIC ACIDS RESEARCH (2016)
Viable RNaseH1 knockout mice show RNaseH1 is essential for R loop processing, mitochondrial and liver function
Walt F. Lima et al.
NUCLEIC ACIDS RESEARCH (2016)
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity
Xue-Hai Liang et al.
NUCLEIC ACIDS RESEARCH (2016)
Development of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions
Timothy A. Vickers et al.
PLOS ONE (2016)
Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs
Sabine Sewing et al.
PLOS ONE (2016)
Development of a Method for Profiling Protein Interactions with LNA-Modified Antisense Oligonucleotides Using Protein Microarrays
Satoko Kakiuchi-Kiyota et al.
NUCLEIC ACID THERAPEUTICS (2016)
Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides
Takeshi Kasuya et al.
Scientific Reports (2016)
Efficient Synthesis and Biological Evaluation of 5′-GalNAc Conjugated Antisense Oligonucleotides
Michael E. Ostergaard et al.
BIOCONJUGATE CHEMISTRY (2015)
Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects
Dennis Mircsof et al.
NATURE NEUROSCIENCE (2015)
Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages
Xue-hai Liang et al.
NUCLEIC ACIDS RESEARCH (2015)
The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA
Timothy A. Vickers et al.
NUCLEIC ACIDS RESEARCH (2015)
In silico and in vitro evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization
Piotr J. Kamola et al.
NUCLEIC ACIDS RESEARCH (2015)
2′-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF
Wen Shen et al.
NUCLEIC ACIDS RESEARCH (2015)
Apoptosis Triggers Specific, Rapid, and Global mRNA Decay with 3′ Uridylated Intermediates Degraded by DIS3L2
Marshall P. Thomas et al.
CELL REPORTS (2015)
Antisense Oligonucleotide Therapies: The Promise and the Challenges from a Toxicologic Pathologist's Perspective
Kendall S. Frazier
TOXICOLOGIC PATHOLOGY (2015)
Phosphorothioate oligonucleotides can displace NEAT1 RNA and form nuclear paraspeckle-like structures
Wen Shen et al.
NUCLEIC ACIDS RESEARCH (2014)
Sequence motifs associated with hepatotoxicity of locked nucleic acid-modified antisense oligonucleotides
Andrew D. Burdick et al.
NUCLEIC ACIDS RESEARCH (2014)
TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells
Xue-hai Liang et al.
NUCLEIC ACIDS RESEARCH (2014)
Comparison of Hepatic Transcription Profiles of Locked Ribonucleic Acid Antisense Oligonucleotides: Evidence of Distinct Pathways Contributing to Non-target Mediated Toxicity in Mice
Satoko Kakiuchi-Kiyota et al.
TOXICOLOGICAL SCIENCES (2014)
Quantum Mechanical Studies of DNA and LNA
Troels Koch et al.
NUCLEIC ACID THERAPEUTICS (2014)
Topoisomerases facilitate transcription of long genes linked to autism
Ian F. King et al.
NATURE (2013)
Hepatotoxic Potential of Therapeutic Oligonucleotides Can Be Predicted from Their Sequence and Modification Pattern
Peter H. Hagedorn et al.
NUCLEIC ACID THERAPEUTICS (2013)
Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs
Clotilde Lagier-Tourenne et al.
NATURE NEUROSCIENCE (2012)
Chemical Modification Study of Antisense Gapmers
Robert Stanton et al.
NUCLEIC ACID THERAPEUTICS (2012)
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Magdalini Polymenidou et al.
NATURE NEUROSCIENCE (2011)
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
Eric E. Swayze et al.
NUCLEIC ACIDS RESEARCH (2007)
Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs
HJ Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
PSF and p54nrb/NonO -: multi-functional nuclear proteins
Y Shav-Tal et al.
FEBS LETTERS (2002)
Share Paper
